KLF1 Gene Lutheran Null Phenotype & Inhibitor Genetic Test in UAE | 2800 AED

Executive Summary & Core Metrics

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited NGS Processing.
✓ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
✓ Clinical Guidance: Telephonic Post-Test Clinical Interpretation & Actionable Insights.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The KLF1 Gene Lutheran inhibitor blood group test uses next-generation sequencing (NGS) to identify pathogenic variants causing the Lutheran null phenotype and associated inhibitor risks, critical for safe transfusions and managing hemolytic disease of the fetus and newborn. This molecular analysis offers single-nucleotide resolution, distinguishing silent carriers from confirmed cases.

Feature	Our KLF1 NGS Test	Closest Alternative (Serology)
Precision	Single‑nucleotide resolution, full gene coverage	Phenotype only; cannot detect silent carriers
Methodology	NGS (Next Generation Sequencing)	Agglutination / phenotype screening
Turnaround	3-4 Weeks	1-2 Days (but incomplete)
Clinical Utility	Definitive genotyping, inhibitor risk prediction	Requires confirmatory DNA testing

Physician Insight & Safety Protocols

Note from Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA Registration ID: 9294403): “This genetic analysis provides a permanent, molecular definition of the Lutheran blood group status. However, results must always be interpreted alongside a complete transfusion history and family pedigree – a normal result does not exclude all forms of alloimmunization. Any clinical decision should involve a hematologist or transfusion medicine specialist.”

Pre-Test Medication Advisory

⚠ Medication Advisory

Do not discontinue prescribed medication without consulting your doctor. Anticoagulants or antiplatelet agents do not interfere with DNA extraction, but inform the laboratory of all drugs taken.

Exclusion Criteria & Emergency Red Flags

🚨 Exclusion Criteria & Emergency Red Flags

Exclusion Criteria:

Inability to provide informed consent or complete genetic counseling.
Patient currently in a hemolytic crisis requiring urgent transfusion – stabilize first.
Sample inadequacy (hemolyzed, clotted, or insufficient quantity).

Seek Emergency Care Immediately if:

Sudden dark urine, jaundice, or severe fatigue (signs of acute hemolysis).
Shortness of breath, chest pain, or back pain after a transfusion.
Pregnant patient with reduced fetal movements – go to emergency obstetrics.

Patient FAQ & Clinical Guidance

1. What does this KLF1 Lutheran blood group test detect, and who should consider it?

This next‑generation sequencing test analyzes the KLF1 gene to identify mutations causing Lutheran null phenotype and inhibitor risk, guiding safe transfusion and pregnancy management. It is recommended for patients with antibodies against Lutheran antigens or a family history of hemolytic disease of the newborn.

2. How is the test performed, and what is the sample requirement?

A single blood draw, a one‑drop blood card (FTA), or previously extracted DNA is accepted. Our VIP mobile phlebotomy service provides a cold‑chain home collection within 24 hours across Dubai. The sample is processed using NGS in an ISO‑accredited laboratory.

3. What actions should I take after receiving a positive result?

A positive finding means you carry a disease‑associated KLF1 variant. Immediate genetic counseling and a consultation with a transfusion medicine specialist are mandatory. Our post‑test telephonic guidance will help you coordinate these next steps.

UAE Regulatory & Data Privacy Adherence

This test is conducted under the legal framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and safety are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is encrypted and handled with strict confidentiality.

Clinical & Logistical Metadata

Test Name	KLF1 Gene Lutheran Null Phenotype & Inhibitor Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3-4 Weeks
Sample Type / Matrix	Whole Blood, FTA Card, or Extracted DNA
Methodology Used	Next-Generation Sequencing (NGS)
ICD-10-CM Code	Z13.79, P55.8, Z84.81
LOINC Code	82939-0
DHA Facility License & Laboratory Address	DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| DNA Labs UAE